<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ANG</journal-id>
<journal-id journal-id-type="hwp">spang</journal-id>
<journal-id journal-id-type="nlm-ta">Angiology</journal-id>
<journal-title>Angiology</journal-title>
<issn pub-type="ppub">0003-3197</issn>
<issn pub-type="epub">1940-1574</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0003319712464815</article-id>
<article-id pub-id-type="publisher-id">10.1177_0003319712464815</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Coronary Heart Disease</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Predictors of Coronary Lesions Complexity in Patients With Stable Coronary Artery Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Aksakal</surname>
<given-names>Enbiya</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712464815">1</xref>
<xref ref-type="corresp" rid="corresp1-0003319712464815"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tanboga</surname>
<given-names>Ibrahim Halil</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712464815">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kurt</surname>
<given-names>Mustafa</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0003319712464815">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kaya</surname>
<given-names>Ahmet</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0003319712464815">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Topcu</surname>
<given-names>Selim</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712464815">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kalkan</surname>
<given-names>Kamuran</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712464815">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sevimli</surname>
<given-names>Serdar</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712464815">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0003319712464815"><label>1</label>Department of Cardiology, Ataturk University Medical School, Heart Center, Erzurum, Turkey</aff>
<aff id="aff2-0003319712464815"><label>2</label>Department of Cardiology, Erzurum Education and Research Hospital, Erzurum, Turkey</aff>
<author-notes>
<corresp id="corresp1-0003319712464815">Enbiya Aksakal, Atatürk Üniversitesi Tıp Fakültesi, Kalp Merkezi, Kardiyoloji Anabilim Dalı 25100, Yakutiye, Erzurum, Turkey. Email: <email>drenbiya@yahoo.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2013</year>
</pub-date>
<volume>64</volume>
<issue>4</issue>
<fpage>304</fpage>
<lpage>309</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Only a few studies focused on the predictors of the SYNTAX score (SS). We evaluated the independent clinical predictors of SS in 436 consecutive patients with stable angina pectoris who underwent coronary angiography. Estimated glomerular filtration rate (eGFR) was calculated. The mean SS was 25.8 ± 13.7. High-sensitivity C-reactive protein and low-density lipoprotein cholesterol levels gradually rise while high-density lipoprotein cholesterol (HDL-C), triglycerides, and eGFR levels gradually decline from low to high SS tertile. Multivariate logistic regression analysis revealed that diabetes (<italic>P </italic>= .005), left ventricular ejection fraction ([LVEF]; <italic>P </italic>&lt; .001), previous statin use (<italic>P </italic>= .02), HDL-C level (<italic>P </italic>&lt; .001), and eGFR (<italic>P </italic>&lt; .001) were independent predictors of SS. In conclusion, the presence of diabetes mellitus, no previous statin use, and lower values of HDL-C, LVEF, and eGFR were independent predictors of coronary heart disease complexity. This study has been accepted to present at the 28th Turkish National Cardiology Congress.</p>
</abstract>
<kwd-group>
<kwd>coronary heart disease</kwd>
<kwd>SYNTAX score</kwd>
<kwd>clinical predictors</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0003319712464815">
<title>Introduction</title>
<p>Knowledge of coronary lesion complexity is useful when deciding treatment modalities like coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI).<sup>
<xref ref-type="bibr" rid="bibr1-0003319712464815">1</xref>
<xref ref-type="bibr" rid="bibr2-0003319712464815"/>–<xref ref-type="bibr" rid="bibr3-0003319712464815">3</xref>
</sup> Furthermore, coronary lesion complexity predicts adverse long-term cardiovascular events in patients that undergo PCI or CABG.<sup>
<xref ref-type="bibr" rid="bibr4-0003319712464815">4</xref>
<xref ref-type="bibr" rid="bibr5-0003319712464815"/>–<xref ref-type="bibr" rid="bibr6-0003319712464815">6</xref>
</sup> The SYNTAX (Synergy between PCI with TAXUS and Cardiac Surgery) score (SS) is used to assess coronary lesion complexity.<sup>
<xref ref-type="bibr" rid="bibr7-0003319712464815">7</xref>
</sup> Many studies have reported that as the SS increases, revascularization options change and the rate of adverse long-term cardiovascular events rises.<sup>
<xref ref-type="bibr" rid="bibr1-0003319712464815">1</xref>,<xref ref-type="bibr" rid="bibr4-0003319712464815">4</xref>
</sup> To date, only a few studies have focused on the predictors of SS. Therefore, we evaluated the independent clinical predictors of SS in patients with stable angina pectoris (SAP).</p>
</sec>
<sec id="section2-0003319712464815" sec-type="methods">
<title>Methods</title>
</sec>
<sec id="section3-0003319712464815">
<title>Study Population</title>
<p>We enrolled 436 consecutive patients with SAP who underwent coronary angiography for suspected coronary heart disease (CHD) from January 2011 to June 2011. Patients with acute coronary syndrome (ACS), SS = 0, history of previous myocardial infarction, CABG or PCI, acute or chronic inflammatory and infectious disease, and patients using steroids were excluded from the study. </p>
<p>Blood sample for high-sensitivity C-reactive protein (hsCRP), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) were collected in a fasting state 1 day before coronary angiography. Transthoracic echocardiography was performed and biplane Simpson ejection fraction (%) was calculated before coronary angiography. Hypertension was defined as having at least 2 blood pressure measurements &gt;140/90 mm Hg or using antihypertensive drugs. Diabetes mellitus (DM) was defined as having at least 2 fasting blood sugar measurements &gt;126 mg/dL or using antidiabetic drugs. Body mass index values were calculated based on the height and weight of each patient. Estimated glomerular filtration rate (eGFR) was calculated by the Cockcroft-Gault formula ([140 − age] × [weight in kg] × [0.85 if female]/[72 × creatinine]). Medications used prior to coronary angiography were noted. Informed consent was obtained from all patients during hospitalization, and the study protocol was approved by our institutional review board.</p>
<sec id="section4-0003319712464815">
<title>SYNTAX Score</title>
<p>SYNTAX score (SS) is an angiographic tool used in grading the complexity of CHD. Each coronary lesion with a diameter stenosis ≥50%, in vessels ≥1.5 mm must be scored. Parameters of the SS are shown in <xref ref-type="table" rid="table1-0003319712464815">Table 1</xref>. The online latest updated version (2.03) was used to calculate the SS (www.syntaxscore.com). The SS was classified as tertiles, low SS (≤22), intermediate SS (23-32), and high SS (≥33). All angiographic variables of SS were computed by 2 experienced cardiologists (E.A. and I.H.T.) who were blinded to procedural data and clinical outcome. In case of disagreement, the final decision was made by consensus. </p>
<table-wrap id="table1-0003319712464815" position="float">
<label>Table 1.</label>
<caption>
<p>SYNTAX Score Parameters (<ext-link ext-link-type="uri" xlink:href="www.syntaxscore.com">www.syntaxscore.com</ext-link>).</p>
</caption>
<graphic alternate-form-of="table1-0003319712464815" xlink:href="10.1177_0003319712464815-table1.tif"/>
<table>
<thead>
<tr>
<th>Parameters</th>
<th>Definition</th>
</tr>
</thead>
<tbody>
<tr>
<td>Number of total lesions</td>
<td>Each coronary lesion with a diameter stenosis ≥50% in vessels ≥1.5 mm must be scored. </td>
</tr>
<tr>
<td>Dominance</td>
<td>Right dominance: the posterior descending coronary artery is a branch of the right coronary artery;left dominance: the posterior descending artery is a branch of the left coronary artery. Codominance does not exist as an option in the SYNTAX score.</td>
</tr>
<tr>
<td>Total occlusion</td>
<td>No intraluminal antegrade flow (TIMI 0) beyond the point of occlusion. However, antegrade flow beyond the total occlusion might be maintained by bridging collaterals and/or ipsi collaterals.</td>
</tr>
<tr>
<td>Trifurcation</td>
<td>A trifurcation is a division of a main branch into 3 branches of at least 1.5 mm</td>
</tr>
<tr>
<td>Bifurcation</td>
<td>A bifurcation is a division of a main parent branch into 2 daughter branches of at least 1.5 mm. Bifurcation lesions may involve the proximal main vessel, the distal main vessel, and the side branch according to the Medina classification. The smaller of the 2 daughter branches should be designated as the “side branch.” In case of the main stem either the LCX or the LAD can be designated as the side branch depending on their respective calibers.</td>
</tr>
<tr>
<td>Aorto-ostial</td>
<td>A lesion is classified as aorto-ostial when it is located immediately at the origin of the coronary vessels from the aorta.</td>
</tr>
<tr>
<td>Severe tortuosity</td>
<td>One or more bends of 90° or more, or 3 or more bends of 45° to 90° proximal of the diseased segment.</td>
</tr>
<tr>
<td>Length &gt;20 mm</td>
<td>Estimation of the length of that portion of the stenosis that has ≥50% reduction in luminal diameter in the projection where the lesion appears to be the longest. (In case of a bifurcation lesion at least 1 of the branches has a lesion length of &gt;20 mm.)</td>
</tr>
<tr>
<td>Heavy Calcification</td>
<td>Multiple persisting opacifications of the coronary wall visible in more than 1 projection surrounding the complete lumen of the coronary artery at the site of the lesion.</td>
</tr>
<tr>
<td>Thrombus</td>
<td>Spheric, ovoid, or irregular intraluminal filling defect or lucency surrounded on 3 sides by contrast medium seen just distal or within the coronary stenosis in multiple projections or a visible embolization of intraluminal material downstream</td>
</tr>
<tr>
<td>Diffuse disease/small vessel disease</td>
<td>Present when at least 75% of the length of any segment(s) proximal to the lesion, at the site of the lesion or distal to the lesion has a vessel diameter of &lt;2 mm.</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="section5-0003319712464815">
<title>Statistics</title>
<p>Baseline clinical and angiographic characteristics were represented as mean ± standard deviation or median for continuous variables and counts or percentage for categorical variables. Continuous variables between 2 groups were compared with Student <italic>t</italic> test or Mann-Whitney <italic>U</italic> test, between more than 2 groups were compared with one-way analysis of variance or Kruskal-Wallis tests. Categorical variables were compared with chi-square or Fisher exact test, as appropriate. Spearman or Pearson correlation analyses were used, as appropriate. To determine the independent predictors of coronary lesions complexity, multivariate logistic regression analysis was performed among the variables found to be significant in univariate analysis (<italic>P</italic> &lt; .05). Receiver–operating characteristic (ROC) analyses was used to compare the performance and prognostic power of the HDL-C, left ventricular ejection fraction (LVEF), and eGFR for high SS. The predictive validities were quantified as the area under the ROC curves (<italic>c</italic> statistics), and the comparisons of <italic>c</italic> statistics were performed by MedCalc statistic software (version 11.3.8.0, Mariakerke, Belgium). A 2-sided <italic>P</italic> value &lt;.05 was considered significant in all analyses. Data were analyzed using SPSS 15.0 version (SPSS Inc, Chicago, Illinois).</p>
</sec>
</sec>
<sec id="section6-0003319712464815">
<title>Results</title>
<p>A total of 436 consecutive patients with SAP (mean age 61 ± 11.9; 75% male) were enrolled in the study. The mean SS was 25.8 ± 13.7 (median, 23; interquartile range, 15-36; <xref ref-type="fig" rid="fig1-0003319712464815">Figure 1</xref>). The distribution of the study population relative to the tertiles of SS was as follows: 48.6% in the low tertile, 21.8% in the intermediate tertile, and 29.6% in the high tertile. </p>
<fig id="fig1-0003319712464815" position="float">
<label>Figure 1.</label>
<caption>
<p>Histograms of Syntax score with superimposed normal curves in the our population.</p>
</caption>
<graphic xlink:href="10.1177_0003319712464815-fig1.tif"/>
</fig>
<p>Clinical, biochemical, and angiographic characteristics of the SS tertiles are shown in <xref ref-type="table" rid="table2-0003319712464815">Tables 2</xref> and <xref ref-type="table" rid="table3-0003319712464815">3</xref>. Diabetes mellitus incidence gradually increased while LVEF levels and previous use of statin incidence gradually declined from low- to high-SS tertile. Similarly, hsCRP and LDL-C levels gradually rise while HDL-C, TG, and eGFR levels gradually decline. Multivariate logistic regression analysis aiming to determine the predictors of high SS revealed that DM presence (odds ratio [OR]: 2.20; confidence interval [CI] 1.26-3.82; <italic>P</italic> = .005), LVEF level (OR: 0.92; CI: 0.89-0.94; <italic>P</italic> &lt; .001), previous statin use (OR: 0.44; CI: 0.22-0.90; <italic>P</italic> = .02), HDL-C level (OR: 0.96; CI: 0.94-0.98; <italic>P</italic> &lt; .001), and eGFR level (OR: 0.98; CI: 0.97-0.99; <italic>P</italic> &lt; .001) were the independent predictors of SS (<xref ref-type="table" rid="table4-0003319712464815">Table 4</xref>).</p>
<table-wrap id="table2-0003319712464815" position="float">
<label>Table 2.</label>
<caption>
<p>Baseline Clinical Characteristics According to SYNTAX Score (SS) Tertiles.</p>
</caption>
<graphic alternate-form-of="table2-0003319712464815" xlink:href="10.1177_0003319712464815-table2.tif"/>
<table>
<thead>
<tr>
<th>Variables</th>
<th>Low SS, n = 212</th>
<th>Intermediate SS, n = 95</th>
<th>High SS, n = 129</th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age, years</td>
<td>61.2 ± 12.2</td>
<td>60.5 ± 12.1</td>
<td>62.4 ± 11.3</td>
<td>.54</td>
</tr>
<tr>
<td>Male, %</td>
<td>71.7</td>
<td>80</td>
<td>78.6</td>
<td>.18</td>
</tr>
<tr>
<td>BMI, kg/m<sup>2</sup>
</td>
<td>28.2 ± 6.3</td>
<td>29.3 ± 5.6</td>
<td>27.7 ± 3.8</td>
<td>.07</td>
</tr>
<tr>
<td>Diabetes, %</td>
<td>16.5</td>
<td>22.1</td>
<td>28.2</td>
<td>.03</td>
</tr>
<tr>
<td>Hypertension,%</td>
<td>45.8</td>
<td>50.5</td>
<td>53.4</td>
<td>.36</td>
</tr>
<tr>
<td>Smoking, %</td>
<td>39.6</td>
<td>44.2</td>
<td>36.6</td>
<td>.51</td>
</tr>
<tr>
<td>LVEF, %</td>
<td>54 ± 9.5</td>
<td>47.6 ± 9.5</td>
<td>44.7 ± 9.3</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>CKD, %</td>
<td>11.8</td>
<td>12.6</td>
<td>18.3</td>
<td>.21</td>
</tr>
<tr>
<td>Medication, %</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Aspirin</td>
<td>17</td>
<td>18</td>
<td>19</td>
<td>.94</td>
</tr>
<tr>
<td> ACE-i/ARB</td>
<td>24.1</td>
<td>28.4</td>
<td>30</td>
<td>.46</td>
</tr>
<tr>
<td> CCB</td>
<td>8.5</td>
<td>7.4</td>
<td>11.5</td>
<td>.52</td>
</tr>
<tr>
<td> Beta-blocker</td>
<td>6.6</td>
<td>7.4</td>
<td>7.6</td>
<td>.93</td>
</tr>
<tr>
<td> Statin</td>
<td>19</td>
<td>16</td>
<td>11</td>
<td>.03</td>
</tr>
<tr>
<td>hsCRP, mg/L</td>
<td>1.47 ± 0.75</td>
<td>1.78 ± 0.91</td>
<td>2.11 ± 2.24</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>LDL-C, mg/dL</td>
<td>97 ± 39</td>
<td>111 ± 36</td>
<td>130 ± 36</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>HDL-C, mg/dL</td>
<td>41 ± 11</td>
<td>38 ± 14</td>
<td>35 ± 11</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>TG, mg/dL</td>
<td>118 (81-164)</td>
<td>133 (91-168)</td>
<td>134 (113-173)</td>
<td>.002</td>
</tr>
<tr>
<td>eGFR, mL/min per 1.73 m<sup>2</sup>
</td>
<td>89.0 ± 27.9</td>
<td>91.8 ± 27.8</td>
<td>81 ± 25</td>
<td>.008</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0003319712464815">
<p>Abbreviations: ACE-i/ARB, angiotensin converting enzyme inhibitor/angiotensin receptor blocker; BMI, body mass index; CCB, calcium channel blocker; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; HDL-C, high-density lipoprotein cholesterol; hsCRP, high-sensitivity C-reactive protein; LDL-C, low-density lipoprotein cholesterol; LVEF, left ventricular ejection fraction; TG, triglyceride.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table3-0003319712464815" position="float">
<label>Table 3.</label>
<caption>
<p>Angiographical Characteristics According to SYNTAX Score (SS) Tertiles.</p>
</caption>
<graphic alternate-form-of="table3-0003319712464815" xlink:href="10.1177_0003319712464815-table3.tif"/>
<table>
<thead>
<tr>
<th>Variables</th>
<th>Low SS, n = 212</th>
<th>Intermediate SS, n = 95</th>
<th>High SS, n = 129</th>
</tr>
</thead>
<tbody>
<tr>
<td>No. of lesions, median</td>
<td>4</td>
<td>6</td>
<td>8</td>
</tr>
<tr>
<td>Dominance—right, %</td>
<td>82.1</td>
<td>80</td>
<td>91</td>
</tr>
<tr>
<td>Chronic total occlusion, %</td>
<td>11.8</td>
<td>27.4</td>
<td>47.7</td>
</tr>
<tr>
<td>Bifurcation, %</td>
<td>25.9</td>
<td>37.9</td>
<td>44.6</td>
</tr>
<tr>
<td>Aorto-ostial, %</td>
<td>7.5</td>
<td>15.8</td>
<td>16.2</td>
</tr>
<tr>
<td>Diffuse/small, %</td>
<td>6.1</td>
<td>9.5</td>
<td>14.8</td>
</tr>
<tr>
<td>Heavy calcification, %</td>
<td>3.3</td>
<td>5.3</td>
<td>10.9</td>
</tr>
<tr>
<td>Thrombus, %</td>
<td>8.5</td>
<td>8.4</td>
<td>6.9</td>
</tr>
<tr>
<td>Long lesion, %</td>
<td>29.2</td>
<td>38.9</td>
<td>56.2</td>
</tr>
<tr>
<td>Tortuosity, %</td>
<td>6.6</td>
<td>10.5</td>
<td>14.7</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="table4-0003319712464815" position="float">
<label>Table 4.</label>
<caption>
<p>Independent Predictors of High SYNTAX Score (Multivariate Logistic Regression Analysis).</p>
</caption>
<graphic alternate-form-of="table4-0003319712464815" xlink:href="10.1177_0003319712464815-table4.tif"/>
<table>
<thead>
<tr>
<th>Variables</th>
<th>Univariate OR (95% CI)</th>
<th>
<italic>P</italic>
</th>
<th>Multivariate OR (95% CI)</th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Diabetes mellitus</td>
<td>1.80 (1.11-2.91)</td>
<td>.015</td>
<td>2.13 (1.23-3.67)</td>
<td>.006</td>
</tr>
<tr>
<td>Ejection fraction</td>
<td>0.93 (0.90-0.95)</td>
<td>&lt;.001</td>
<td>0.92 (0.90-0.94)</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>HDL-C</td>
<td>0.97 (0.95-0.99)</td>
<td>.001</td>
<td>0.96 (0.94-0.98)</td>
<td>.001</td>
</tr>
<tr>
<td>Previous statin use</td>
<td>0.53 (0.29-0.97)</td>
<td>.038</td>
<td>0.44 (0.22-0.89)</td>
<td>.022</td>
</tr>
<tr>
<td>Estimated GFR</td>
<td>0.98 (0.98-0.99)</td>
<td>.003</td>
<td>0.98 (0.97-0.99)</td>
<td>&lt;.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0003319712464815">
<p>Abbreviations: CI, confidence interval; HDL-C, high-density lipoprotein cholesterol; GFR, glomerular filtration rate; OR, odds ratio,</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In correlation analysis, there were significant correlation between SS and HDL-C (<italic>r</italic> = −.163, <italic>P</italic> = .001), eGFR (<italic>r</italic> = −.108, <italic>P</italic> = .023) versus LVEF (<italic>r</italic> = −.370, <italic>P </italic>&lt; .001; <xref ref-type="fig" rid="fig2-0003319712464815">Figure 2</xref>). The c indices were .593 (.545-.640), .581 (.533-.628), and .708 (.662-.750) for HDL-C, eGFR, and LVEF, respectively (<xref ref-type="fig" rid="fig3-0003319712464815">Figure 3</xref>). Comparison of ROC curve analysis revealed that the best discriminator was LVEF (<italic>c</italic> statistics <italic>P</italic> for eGFR vs HDL-C .779, <italic>c</italic> statistics <italic>P</italic> for eGFR vs LVEF .001, and <italic>c</italic> statistics <italic>P</italic> for LVEF vs HDL-C .002).</p>
<fig id="fig2-0003319712464815" position="float">
<label>Figure 2.</label>
<caption>
<p>Correlations of Syntax score with LV-EF, estimated GFR and HDL-C.</p>
</caption>
<graphic xlink:href="10.1177_0003319712464815-fig2.tif"/>
</fig>
<fig id="fig3-0003319712464815" position="float">
<label>Figure 3.</label>
<caption>
<p>Comparison of ROC-Curves in prediction of high Syntax score.</p>
</caption>
<graphic xlink:href="10.1177_0003319712464815-fig3.tif"/>
</fig>
</sec>
<sec id="section7-0003319712464815">
<title>Discussion</title>
<p>We demonstrated that the complexity of CHD assessed by SS might be predictable using clinical variables. Presence of DM, no previous statin use, and lower values of HDL-C, LVEF, and eGFR were independent predictors of CHD complexity.</p>
<p>The SS was developed for the grading of coronary complexity based on angiographic visual assessment.<sup>
<xref ref-type="bibr" rid="bibr7-0003319712464815">7</xref>
</sup> It has been shown to be reproducible (interobserver and intraobserver) and it is recommended for clinical practice.<sup>
<xref ref-type="bibr" rid="bibr8-0003319712464815">8</xref>
</sup> Many studies have reported that elevated SS (ie, increased coronary complexity) is associated with higher rates of long-term major adverse cardiovascular events and revascularization after PCI or CABG.<sup>
<xref ref-type="bibr" rid="bibr2-0003319712464815">2</xref>,<xref ref-type="bibr" rid="bibr3-0003319712464815">3</xref>,<xref ref-type="bibr" rid="bibr9-0003319712464815">9</xref>,<xref ref-type="bibr" rid="bibr10-0003319712464815">10</xref>
</sup> The SS scoring system produces a numerical value mainly based on coronary lesion dominance and number of total lesions, while also evaluating the presence of other lesions with complex angiographic properties such as chronic total occlusion (CTO), bifurcation lesions, aorto-ostial lesions, heavy calcific lesions, diffuse small vessel disease, tortuous lesions, thrombotic lesions, and long lesions.<sup>
<xref ref-type="bibr" rid="bibr7-0003319712464815">7</xref>
</sup>
</p>
<p>In our study, presence of DM, no previous statin use, lower values of HDL-C, LVEF, and eGFR were found to be independent predictors of coronary complexity. Yan et al<sup>
<xref ref-type="bibr" rid="bibr11-0003319712464815">11</xref>
</sup> determined that advanced age, male gender, DM, and eGFR were independent predictors of SS. However, their study group was mainly populated by patients with ACS (approximately 85%), while excluding patients using statins. The SS was first validated by the SYNTAX study, whereas ST segment elevation myocardial infarction (STEMI) cases were not included in this study.<sup>
<xref ref-type="bibr" rid="bibr1-0003319712464815">1</xref>
</sup> However, later on, the same team reported that SS was also useful in STEMI cases.<sup>
<xref ref-type="bibr" rid="bibr12-0003319712464815">12</xref>,<xref ref-type="bibr" rid="bibr13-0003319712464815">13</xref>
</sup> Since we believe that the SS is not definitively validated for patients with STEMI, we did not include patients with STEMI in our study. </p>
<p>Diabetic patients are known to have increased atherosclerotic burden as well as higher rates for multivessel disease and high number of complex lesions such as long lesions, bifurcation lesions, and diffuse small vessel disease.<sup>
<xref ref-type="bibr" rid="bibr14-0003319712464815">14</xref>
<xref ref-type="bibr" rid="bibr15-0003319712464815"/>
<xref ref-type="bibr" rid="bibr16-0003319712464815"/>–<xref ref-type="bibr" rid="bibr17-0003319712464815">17</xref>
</sup> In chronic kidney disease, atherosclerosis shows a faster course and more diffuse nature with complex coronary lesions being more common.<sup>
<xref ref-type="bibr" rid="bibr18-0003319712464815">18</xref>
<xref ref-type="bibr" rid="bibr19-0003319712464815"/>
<xref ref-type="bibr" rid="bibr20-0003319712464815"/>–<xref ref-type="bibr" rid="bibr21-0003319712464815">21</xref>
</sup> Low HDL-C is a CHD risk factor. Furthermore, low HDL-C has been found to be a predictor of CHD extent and severity in many studies.<sup>
<xref ref-type="bibr" rid="bibr18-0003319712464815">18</xref>,<xref ref-type="bibr" rid="bibr22-0003319712464815">22</xref>,<xref ref-type="bibr" rid="bibr23-0003319712464815">23</xref>
</sup> Low ejection fraction is not the cause of complex lesions, but its outcome is. As the SS increases, the number of complex lesions such as CTO, bifurcation, and ostial lesions increases. It is apparent that such angiographic lesion properties have an effect over ventricular systolic functions. </p>
<p>Since we applied a cross-sectional study design, our findings cannot explain the cause–effect relationship and our single-center results cannot be generalized to the entire Turkish population. Besides, this study included only patients with SAP and excluded patients with ACS. Finally, because our study had no clinical follow-up parameters, we were not able to carry out a detailed analysis in this regard. </p>
<p>In conclusion, patients with stable coronary artery disease, presence of diabetes, having no history of previous statin use, lower values of HDL-C, LVEF, and eGFR are found to be the independent predictors of coronary artery complexity. In such settings, it should be taken into account that the complex coronary lesions will be more common.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-0003319712464815">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0003319712464815">
<label>Funding</label>
<p>The authors received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0003319712464815">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serruys</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Morice</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Kappetein</surname>
<given-names>AP</given-names>
</name>
<etal/>
</person-group>. <article-title>Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease</article-title>. <source>N Engl J Med</source>. <year>2009</year>;<volume>360</volume>(<issue>10</issue>):<fpage>961</fpage>–<lpage>972</lpage>.</citation>
</ref>
<ref id="bibr2-0003319712464815">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kappetein</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Mack</surname>
<given-names>MJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial</article-title>. <source>Eur Heart J</source>. <year>2011</year>;<volume>32</volume>(<issue>17</issue>):<fpage>2125</fpage>–<lpage>2134</lpage>.</citation>
</ref>
<ref id="bibr3-0003319712464815">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morice</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Serruys</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Kappetein</surname>
<given-names>AP</given-names>
</name>
<etal/>
</person-group>. <article-title>Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) trial</article-title>. <source>Circulation</source>. <year>2010</year>;<volume>121</volume>(<issue>24</issue>):<fpage>2645</fpage>–<lpage>2653</lpage>.</citation>
</ref>
<ref id="bibr4-0003319712464815">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capodanno</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Capranzano</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Di Salvo</surname>
<given-names>ME</given-names>
</name>
<etal/>
</person-group>. <article-title>Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft</article-title>. <source>JACC Cardiovasc Interv</source>. <year>2009</year>;<volume>2</volume>(<issue>8</issue>):<fpage>731</fpage>–<lpage>738</lpage>.</citation>
</ref>
<ref id="bibr5-0003319712464815">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onuma</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Girasis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Piazza</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries</article-title>. <source>JACC Cardiovasc Interv</source>. <year>2010</year>;<volume>3</volume>(<issue>6</issue>):<fpage>584</fpage>–<lpage>594</lpage>.</citation>
</ref>
<ref id="bibr6-0003319712464815">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valgimigli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Serruys</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Tsuchida</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention</article-title>. <source>Am J Cardiol</source>. <year>2007</year>;<volume>99</volume>(<issue>8</issue>):<fpage>1072</fpage>–<lpage>1081</lpage>.</citation>
</ref>
<ref id="bibr7-0003319712464815">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sianos</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Morel</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Kappetein</surname>
<given-names>AP</given-names>
</name>
<etal/>
</person-group>. <article-title>The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease</article-title>. <source>EuroIntervention</source>. <year>2005</year>;<volume>1</volume>(<issue>2</issue>):<fpage>219</fpage>–<lpage>227</lpage>.</citation>
</ref>
<ref id="bibr8-0003319712464815">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanboga</surname>
<given-names>IH</given-names>
</name>
<name>
<surname>Ekinci</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Isik</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kurt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kaya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sevimli</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Reproducibility of syntax score: from core lab to real world</article-title>. <source>J Interv Cardiol</source>. <year>2011</year>;<volume>24</volume>(<issue>4</issue>):<fpage>302</fpage>–<lpage>306</lpage>.</citation>
</ref>
<ref id="bibr9-0003319712464815">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>SC</given-names>
</name>
<etal/>
</person-group>. <article-title>Complexity of atherosclerotic coronary artery disease and long-term outcomes in patients with unprotected left main disease treated with drug-eluting stents or coronary artery bypass grafting</article-title>. <source>J Am Coll Cardiol</source>. <year>2011</year>;<volume>57</volume>(<issue>21</issue>):<fpage>2152</fpage>–<lpage>2159</lpage>.</citation>
</ref>
<ref id="bibr10-0003319712464815">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>WJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization</article-title>. <source>JACC Cardiovasc Interv</source>. <year>2010</year>;<volume>3</volume>(<issue>6</issue>):<fpage>612</fpage>–<lpage>623</lpage>.</citation>
</ref>
<ref id="bibr11-0003319712464815">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>LQ</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>W</given-names>
</name>
</person-group>. <article-title>The relationship between kidney function and angiographically-derived SYNTAX score</article-title>. <source>Can J Cardiol</source>. <year>2011</year>;<volume>27</volume>(<issue>6</issue>):<fpage>768</fpage>–<lpage>772</lpage>.</citation>
</ref>
<ref id="bibr12-0003319712464815">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Magro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nauta</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Simsek</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Usefulness of the SYNTAX score to predict “no reflow” in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction</article-title>. <source>Am J Cardiol</source>. <year>2012</year>;<volume>109</volume>(<issue>5</issue>):<fpage>601</fpage>–<lpage>606</lpage>.</citation>
</ref>
<ref id="bibr13-0003319712464815">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sarno</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Serruys</surname>
<given-names>PW</given-names>
</name>
<etal/>
</person-group>. <article-title>Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials</article-title>. <source>JACC Cardiovasc Interv</source>. <year>2011</year>;<volume>4</volume>(<issue>1</issue>):<fpage>66</fpage>–<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr14-0003319712464815">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vigorito</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Betocchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bonzani</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Severity of coronary artery disease in patients with diabetes mellitus. Angiographic study of 34 diabetic and 120 nondiabetic patients</article-title>. <source>Am Heart J</source>. <year>1980</year>;<volume>100</volume>(<issue>6 pt 1</issue>):<fpage>782</fpage>–<lpage>787</lpage>.</citation>
</ref>
<ref id="bibr15-0003319712464815">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Gau</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Fulton</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>GD</given-names>
</name>
</person-group>. <article-title>Coronary artery disease in diabetic and nondiabetic patients: a clinical and angiographic comparison</article-title>. <source>Clin Cardiol</source>. <year>1983</year>;<volume>6</volume>(<issue>9</issue>):<fpage>440</fpage>–<lpage>446</lpage>.</citation>
</ref>
<ref id="bibr16-0003319712464815">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baris</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Akdeniz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Uyar</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Are complex coronary lesions more frequent in patients with diabetes mellitus?</article-title> <source>Can J Cardiol</source>. <year>2006</year>;<volume>22</volume>(<issue>11</issue>):<fpage>935</fpage>–<lpage>937</lpage>.</citation>
</ref>
<ref id="bibr17-0003319712464815">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fallow</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>The prevalence, type and severity of cardiovascular disease in diabetic and non-diabetic patients: a matched-paired retrospective analysis using coronary angiography as the diagnostic tool</article-title>. <source>Mol Cell Biochem</source>. <year>2004</year>;<volume>261</volume>(<issue>1-2</issue>):<fpage>263</fpage>–<lpage>269</lpage>.</citation>
</ref>
<ref id="bibr18-0003319712464815">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aksakal</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tanboga</surname>
<given-names>IH</given-names>
</name>
<name>
<surname>Kurt</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>The relation of serum gamma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease</article-title>. <source>Atherosclerosis</source>. <year>2012</year>;<volume>221</volume>(<issue>2</issue>):<fpage>596</fpage>–<lpage>601</lpage>.</citation>
</ref>
<ref id="bibr19-0003319712464815">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coskun</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Orta Kilickesmez</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Abaci</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>The relationship between chronic kidney disease and SYNTAX score</article-title>. <source>Angiology</source>. <year>2011</year>;<volume>62</volume>(<issue>6</issue>):<fpage>504</fpage>–<lpage>508</lpage>.</citation>
</ref>
<ref id="bibr20-0003319712464815">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>LQ</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>W</given-names>
</name>
</person-group>. <article-title>The relationship between kidney function and angiographically-derived SYNTAX score</article-title>. <source>Can J Cardiol</source>. <year>2011</year>;<volume>27</volume>(<issue>6</issue>):<fpage>768</fpage>–<lpage>772</lpage>.</citation>
</ref>
<ref id="bibr21-0003319712464815">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Catapano</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Reiner</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>De Backer</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)</article-title>. <source>Atherosclerosis</source>. <year>2011</year>;<volume>217</volume>(<issue>1</issue>):<fpage>3</fpage>–<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr22-0003319712464815">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romm</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Reagan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rackley</surname>
<given-names>CE</given-names>
</name>
</person-group>. <article-title>Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease</article-title>. <source>Am J Cardiol</source>. <year>1991</year>;<volume>67</volume>(<issue>6</issue>):<fpage>479</fpage>–<lpage>483</lpage>.</citation>
</ref>
<ref id="bibr23-0003319712464815">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sempos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ghali</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ferlinz</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>High-density lipoprotein cholesterol and angiographic coronary artery disease in black patients</article-title>. <source>Am Heart J</source>. <year>1985</year>;<volume>110</volume>(<issue>5</issue>):<fpage>1006</fpage>–<lpage>1011</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>